E
Allurion Technologies Inc. ALUR
$1.67 $0.010.60% NYSE
Recommendation
Prev Close
$1.67
Volume
28,170
Avg Vol (90D)
152,268
Market Cap
$20.47M
Dividend & Yield
--
52-Week Range
$1.02 - $16.81
P/E (TTM)
--
EPS (TTM)
-$11.07
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide ...
11/25/2025 - GuruFocus
Allurion Technologies (ALUR) Reveals Promising Initial Results from Combined Therapy Study
11/25/2025 - GuruFocus
Allurion reports initial results on Allurion Program, tirzepatide combination
11/25/2025 - TipRanks Financial Blog
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence
11/25/2025 - Business Wire
Chardan Capital Reaffirms "Neutral" Rating for Allurion Technologies (NYSE:ALUR)
11/22/2025 - Ticker Report
New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone
11/20/2025 - Business Wire
Allurion Technologies (ALUR) Receives Neutral Rating Confirmation ALUR Stock News
11/20/2025 - GuruFocus
Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer ...
11/18/2025 - GuruFocus
Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
11/18/2025 - Business Wire
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion
11/18/2025 - Zacks Investment Research
4 Medical Product Stocks to Watch From a Challenging Industry
11/17/2025 - Zacks Investment Research
Allurion Technologies Inc (ALUR) Q3 2025 Earnings Call Highlights: Strategic Restructuring and ...
11/12/2025 - GuruFocus
Q3 2025 Allurion Technologies Inc Earnings Call Transcript
11/12/2025 - GuruFocus
Allurion Technologies Inc. (ALUR) Q3 2025 Earnings Call Transcript
11/12/2025 - Seeking Alpha: Transcripts
Allurion Technologies Inc. (ALUR) Q3 2025 Earnings Call Transcript
11/12/2025 - SeekingAlpha
Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update
11/12/2025 - GuruFocus
Allurion Technologies Secures $5M in New Funding
11/12/2025 - TipRanks Financial Blog
Allurion Technologies reports Q3 EPS ($1.53), consensus ($2.45)
11/12/2025 - The Fly
Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update
11/12/2025 - Business Wire
A Look at Allurion Technologies's Upcoming Earnings Report
11/11/2025 - Benzinga
Allurion Technologies (ALUR) Advances Toward FDA Approval for Smart Capsule
11/11/2025 - GuruFocus
Allurion Technologies provides update on Smart Capsule approval process
11/11/2025 - The Fly
Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing
11/11/2025 - Business Wire
Allurion Technologies Inc (ALUR) Q3 2025 Earnings Report Preview: What To Look For
11/11/2025 - GuruFocus
Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025
11/6/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$17.21M
EBITDA (TTM)
-$42.14M
EBIT (TTM)
-$43.18M
Net Income (TTM)
-$43.29M
Balance Sheet
Total Assets (Q)
$18.14M
Total Debt (Q)
$83.29M
Total Liabilities (Q)
$101.07M
Book Value Per Share (Q)
-$10.68
Cash Flow
Cash from Operations (TTM)
-$36.90M
Cash from Investing (TTM)
$0.00
Cash from Financing (TTM)
$14.32M
Net Change in Cash (TTM)
-$22.58M
Filings
Filing Date
Monday, November 17, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Loading...
Beta
1.76
7-Day Total Return
-2.34%
30-Day Total Return
-9.73%
60-Day Total Return
-24.09%
90-Day Total Return
-39.49%
Year to Date Total Return
-83.99%
1-Year Total Return
-80.67%
2-Year Total Return
-98.09%
3-Year Total Return
-99.06%
5-Year Total Return
--
52-week Low
Nov 25, 2025 - $1.02
52-week High
Jan 24, 2025 - $16.81
Valuation
Market Cap
$20.47M - Nano Cap
Enterprise Value
$97.63M
Price/Sales (TTM)
0.75
Price/Book (Q)
-0.16
Dividends and Shares
Shares Outstanding
7.76
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.allurion.com
Phone Number
508 647 4000
Address
11 Huron Drive
Natick, MA 01760
Country
United States
Year Founded
--
Business Description
Sector
Consumer Discretionary
Industry
Consumer Services
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less... more
NYSE 12/12/2025 4:00PM Eastern Quotes delayed